Insider Trading & Ownership - Mayo Stephen

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Mayo Stephen
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-05
Sale
2024-03-06
8:00 pm
Sarepta Therapeutics Inc.SRPTMayo Stephen
Director
3,135$122.96$385,4806,621
(Direct)
View
2023-08-07
Sale
2023-08-09
4:07 pm
Allogene Therapeutics Inc.ALLOMayo Stephen
Director
10,000$4.2855$42,85525,328
(Direct)
View
2022-11-17
Sale
2022-11-21
8:00 pm
Sarepta Therapeutics Inc.SRPTMayo Stephen
Director
858$109.92$94,3116,387
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-05
Option Award
2024-06-07
5:35 pm
N/A
2034-06-05
Allogene Therapeutics Inc.ALLOMayo Stephen
Director
191,082$0191,082
(Direct)
View
2024-05-31
Option Award
2024-06-04
2:32 pm
N/A
N/A
Merck & Co. Inc.MRKMayo Stephen
Director
1,752$125.549,480
(Direct)
View
2024-03-01
Option Award
2024-03-05
8:00 pm
2025-03-01
2034-03-01
Sarepta Therapeutics Inc.SRPTMayo Stephen
Director
5,525$013,435
(Direct)
View
2023-06-13
Option Award
2023-06-15
4:57 pm
N/A
2033-06-13
Allogene Therapeutics Inc.ALLOMayo Stephen
Director
116,120$0116,120
(Direct)
View
2023-05-26
Option Award
2023-05-31
2:39 pm
N/A
N/A
Merck & Co. Inc.MRKMayo Stephen
Director
1,981$111.077,530
(Direct)
View
2023-03-06
Option Award
2023-03-08
8:00 pm
2024-03-06
2033-03-06
Sarepta Therapeutics Inc.SRPTMayo Stephen
Director
4,780$011,167
(Direct)
View
2022-07-08
Option Award
2022-07-12
4:48 pm
N/A
2032-07-08
Allogene Therapeutics Inc.ALLOMayo Stephen
Director
89,815$089,815
(Direct)
View
2022-05-27
Option Award
2022-06-01
4:19 pm
N/A
N/A
Merck & Co. Inc.MRKMayo Stephen
Director
2,364$93.085,398
(Direct)
View
2022-03-07
Option Award
2022-03-09
8:02 pm
2023-03-07
2032-03-07
Sarepta Therapeutics Inc.SRPTMayo Stephen
Director
8,030$012,322
(Direct)
View
2021-11-16
Option Award
2021-11-17
8:06 pm
2022-11-16
2031-11-16
Sarepta Therapeutics Inc.SRPTMayo Stephen
Director
12,530$012,530
(Direct)
View
2021-05-28
Option Award
2021-06-02
1:52 pm
N/A
N/A
Merck & Co. Inc.MRKMayo Stephen
Director
2,635$75.892,855
(Direct)
View
2021-03-15
Option Award
2021-03-17
09:47 am
N/A
N/A
Merck & Co. Inc.MRKMayo Stephen
Director
120$76.23220
(Direct)
View

Ownership
2021-03-17
09:44 am
N/A
N/A
Merck & Co. Inc.MRKMayo Stephen
Director
0$0100
(Direct)
View